Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.51
Data as of Aug 29
 +0.21 / +3.96%
Today’s Change
3.10
Today|||52-Week Range
7.45
+3.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues8.0M76.9M14.0M7.9M
 
 
 
 
 
Cost of Goods Sold0.00--499.0K624.0K
 
 
 
Depreciation And Amortization2.9M2.1M1.3M939.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.1M--12.2M6.3M
 
 
 
 
General Expenses74.7M72.0M47.7M47.0M
 
 
 
 
 
Other Operating Expenses241.0K405.0K0.000.00
 
 
 
Research And Development51.9M53.8M33.0M34.1M
 
 
 
 
 
Total Operating Expenses77.8M74.5M49.5M48.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-69.9M2.5M-35.5M-40.7M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.3M
 
 
Other Expenses0.007.9M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-69.8M10.4M-35.4M-42.9M
 
 
 
 
 
Income Taxes-95.0K0.000.00-362.0K
 
 
 
Net Income-69.7M10.4M-35.4M-42.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.6M33.4M34.8M55.8M
 
 
 
 
 
Shares To Calculate EPS Diluted32.6M33.5M34.8M55.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.14$0.31-$1.02-$0.76
 
 
 
 
 
EPS Diluted-$2.14$0.31-$1.02-$0.76
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.